A detailed history of Van Eck Associates Corp transactions in Illumina, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 129,547 shares of ILMN stock, worth $17.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
129,547
Previous 152,911 15.28%
Holding current value
$17.7 Million
Previous $16 Million 16.02%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$105.28 - $135.9 $2.46 Million - $3.18 Million
-23,364 Reduced 15.28%
129,547 $18.5 Million
Q2 2024

Jul 31, 2024

BUY
$101.05 - $133.57 $428,350 - $566,203
4,239 Added 2.85%
152,911 $16 Million
Q1 2024

Apr 30, 2024

BUY
$127.73 - $147.2 $2.62 Million - $3.02 Million
20,521 Added 16.01%
148,672 $20.4 Million
Q4 2023

Feb 05, 2024

SELL
$92.79 - $142.53 $1.24 Million - $1.91 Million
-13,416 Reduced 9.48%
128,151 $17.8 Million
Q3 2023

Nov 08, 2023

BUY
$128.91 - $192.44 $3.75 Million - $5.6 Million
29,123 Added 25.9%
141,567 $19.4 Million
Q2 2023

Aug 03, 2023

BUY
$183.43 - $232.67 $341,363 - $432,998
1,861 Added 1.68%
112,444 $21.1 Million
Q1 2023

May 03, 2023

SELL
$193.75 - $232.55 $1.11 Million - $1.33 Million
-5,719 Reduced 4.92%
110,583 $25.7 Million
Q4 2022

Feb 08, 2023

BUY
$187.24 - $242.74 $2.94 Million - $3.81 Million
15,678 Added 15.58%
116,302 $23.5 Million
Q3 2022

Oct 27, 2022

SELL
$177.23 - $227.44 $232,880 - $298,856
-1,314 Reduced 1.29%
100,624 $19.2 Million
Q2 2022

Aug 03, 2022

BUY
$181.58 - $368.0 $5.42 Million - $11 Million
29,851 Added 41.41%
101,938 $18.8 Million
Q1 2022

May 10, 2022

SELL
$303.87 - $423.8 $2.05 Million - $2.86 Million
-6,757 Reduced 8.57%
72,087 $25.2 Million
Q4 2021

Jan 26, 2022

SELL
$347.28 - $421.83 $619,894 - $752,966
-1,785 Reduced 2.21%
78,844 $30 Million
Q3 2021

Nov 03, 2021

BUY
$405.61 - $524.84 $2 Million - $2.59 Million
4,938 Added 6.52%
80,629 $32.7 Million
Q2 2021

Aug 10, 2021

BUY
$372.84 - $481.5 $2.21 Million - $2.86 Million
5,935 Added 8.51%
75,691 $35.8 Million
Q1 2021

May 13, 2021

SELL
$361.28 - $504.76 $3.44 Million - $4.81 Million
-9,532 Reduced 12.02%
69,756 $26.8 Million
Q4 2020

Feb 09, 2021

BUY
$292.7 - $370.96 $824,828 - $1.05 Million
2,818 Added 3.69%
79,288 $29.3 Million
Q3 2020

Nov 12, 2020

BUY
$268.51 - $400.74 $161,374 - $240,844
601 Added 0.79%
76,470 $23.6 Million
Q2 2020

Aug 10, 2020

BUY
$256.46 - $373.01 $1.49 Million - $2.17 Million
5,806 Added 8.29%
75,869 $28.1 Million
Q1 2020

May 12, 2020

BUY
$209.2 - $335.53 $1.74 Million - $2.79 Million
8,311 Added 13.46%
70,063 $19.1 Million
Q4 2019

Feb 13, 2020

BUY
$288.29 - $335.49 $1.38 Million - $1.6 Million
4,773 Added 8.38%
61,752 $20.5 Million
Q3 2019

Nov 08, 2019

BUY
$266.84 - $378.23 $1.39 Million - $1.97 Million
5,212 Added 10.07%
56,979 $17.3 Million
Q2 2019

Aug 07, 2019

SELL
$300.59 - $368.15 $4.83 Million - $5.91 Million
-16,061 Reduced 23.68%
51,767 $19.1 Million
Q1 2019

May 13, 2019

BUY
$272.57 - $321.18 $2.27 Million - $2.67 Million
8,320 Added 13.98%
67,828 $21.1 Million
Q4 2018

Feb 12, 2019

SELL
$272.46 - $366.54 $1.65 Million - $2.22 Million
-6,044 Reduced 9.22%
59,508 $17.8 Million
Q3 2018

Nov 13, 2018

SELL
$279.04 - $367.06 $1.63 Million - $2.14 Million
-5,832 Reduced 8.17%
65,552 $24.1 Million
Q2 2018

Aug 13, 2018

SELL
$228.17 - $292.07 $2.97 Million - $3.8 Million
-13,009 Reduced 15.41%
71,384 $19.9 Million
Q1 2018

May 11, 2018

SELL
$209.54 - $253.91 $7.8 Million - $9.46 Million
-37,241 Reduced 30.62%
84,393 $20 Million
Q4 2017

Feb 12, 2018

SELL
$202.23 - $230.03 $7.15 Million - $8.14 Million
-35,379 Reduced 22.53%
121,634 $26.6 Million
Q3 2017

Nov 09, 2017

SELL
$172.3 - $213.93 $852,885 - $1.06 Million
-4,950 Reduced 3.06%
157,013 $31.3 Million
Q2 2017

Aug 11, 2017

BUY
N/A
161,963
161,963 $28.1 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.